feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / NFL Ad's Cancer Test: More Risk Than Relief?

NFL Ad's Cancer Test: More Risk Than Relief?

7 Feb

•

Summary

  • New blood test detects over 50 cancers but has questionable reliability.
  • The test may give a false sense of security, experts warn.
  • Hims & Hers offers the test for $1050, with a discount.
NFL Ad's Cancer Test: More Risk Than Relief?

A new cancer detection blood test, Galleri, is being promoted to a wide audience, including NFL viewers, through Hims & Hers. This test aims to detect over 50 types of cancer before symptoms appear, but its reliability is questioned by medical experts.

The Galleri test analyzes DNA fragments in the blood and can identify the origin of a potential cancer signal. Hims & Hers offers this prescription test as part of a $350 lab testing service, with an additional $700 cost, providing a roughly 25 percent discount from the manufacturer's price.

Experts like Eric Topol highlight that the test is not always reliable on its own, having missed cases in clinical trials. He warns that individuals receiving a "negative, no cancer detected" result might forgo further necessary medical checks.

The test's manufacturer, Grail, states that Galleri is recommended for adults with an elevated risk of cancer, particularly those aged 50 and older. However, Hims & Hers intends to make the prescription available without strict limitations, acknowledging that some cancers can occur earlier.

Grail is seeking FDA approval for Galleri under its most stringent regulatory category. While the test has been sold since 2021, it has not yet been cleared by the FDA as safe and effective, a prerequisite for insurance coverage.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Galleri blood test analyzes DNA fragments in the blood to detect over 50 types of cancer and can pinpoint the origin of a potential cancer signal.
Experts caution that the Galleri test is not always reliable on its own and may provide a false sense of security with negative results, potentially causing individuals to miss further necessary medical checks.
Grail recommends the Galleri test for adults with an elevated cancer risk, especially those 50 and older, and it is available through Hims & Hers for $1,050.

Read more news on

Healthside-arrow
trending

Salesforce lays off 1000

trending

India US trade tariffs slashed

trending

Margot Robbie's Wuthering Heights panned

trending

CBSE board exams: key details

trending

Jana Nayagan movie court case

trending

Dhakshineswar Suresh Davis Cup hero

trending

Deepika Padukone wears Gaurav Gupta

trending

NZ vs UAE match prediction

trending

iPhone 17 Croma Valentine's sale

You may also like

James Sallis: Crime Writer Who Redefined Genre Dies

9 Feb • 2 reads

article image

Death Penalty for Arizona Serial Shooter

18 Dec, 2025 • 284 reads

article image

Couple Denies Starving Daughter, 3, to Death

16 Dec, 2025 • 268 reads

article image

Charlize Theron Tackles Barefoot Climbing in Apex

18 Dec, 2025 • 276 reads

article image

New Blood Test Detects 50 Cancers Early

27 Nov, 2025 • 57 reads

article image